Drug Safety, Parts 1-2U.S. Government Printing Office, 1964 |
From inside the book
Results 1-5 of 20
Page
... manufacturing practice , in ufacture , processing , packing , or holding- Notice of proposed rulemaking-- Press ... Manufacturers As- sociation : Page 42 41 47 50 48 69 61 107 99 , 106 138 137 143 140 G B 88 8 85 64 94 92 63 124 99 , 123 ...
... manufacturing practice , in ufacture , processing , packing , or holding- Notice of proposed rulemaking-- Press ... Manufacturers As- sociation : Page 42 41 47 50 48 69 61 107 99 , 106 138 137 143 140 G B 88 8 85 64 94 92 63 124 99 , 123 ...
Page 30
... manufacturers , wholesalers , and others who handle such drugs to register with FDA , to make their production ... practice of retail pharmacy than to control of drug manufacturing . Over most of the United States traffic in drugs ...
... manufacturers , wholesalers , and others who handle such drugs to register with FDA , to make their production ... practice of retail pharmacy than to control of drug manufacturing . Over most of the United States traffic in drugs ...
Page 35
... manufacture , transportation , storage , or wholesale or retail distribution ... practice . ( 2 ) The label of the drug bears : ( i ) The statement " Caution ... manufacturing history of the package of the drug ; Provided , however , That ...
... manufacture , transportation , storage , or wholesale or retail distribution ... practice . ( 2 ) The label of the drug bears : ( i ) The statement " Caution ... manufacturing history of the package of the drug ; Provided , however , That ...
Page 36
... manufacture , transportation , storage , or wholesale or retail distribution of ... practice . * ( 4 ) Any labeling , as defined in section 201 ( m ) of the act ... manufacturing methods , facilities , controls , and labeling apply to the ...
... manufacture , transportation , storage , or wholesale or retail distribution of ... practice . * ( 4 ) Any labeling , as defined in section 201 ( m ) of the act ... manufacturing methods , facilities , controls , and labeling apply to the ...
Page 64
... manufacturing practice and control to be certain that drugs are produced with proper regard for the protection of ... manufacturers . U.S. DEPARTMENT OF HEALTH , EDUCATION , AND WELFARE FOOD AND DRUG ADMINISTRATION For release in a.m. ...
... manufacturing practice and control to be certain that drugs are produced with proper regard for the protection of ... manufacturers . U.S. DEPARTMENT OF HEALTH , EDUCATION , AND WELFARE FOOD AND DRUG ADMINISTRATION For release in a.m. ...
Other editions - View all
Common terms and phrases
activities additional adequate adverse drug reactions adverse reactions advertisement Advisory agency American Medical Association animals antibiotic approved basic batch Chairman chemical chloramphenicol clinical investigations Commissioner of Food committee concerning contraindications Cosmetic Act Department of Health Drug Administration Drug Amendments drug application drug safety Education established name evaluation exemption experience facilities FDA's Federal Food Federal Register Food and Drug FOUNTAIN GOLDBERG Government GRAY hearing examiner hospitals HUSSEY ingredient inspection investigational drug labeling laboratory LARRICK manufacturing practice medical officers ment new-drug application operations package Packaging and labeling patients pharmaceutical industry Pharmaceutical Manufacturers Association pharmacology Pharmacy physicians prescription drug problems procedures processing proprietary name Public Health question records reports responsible safe samples scientific scientists side effects SMITH specific sponsor staff Stat statement studies subcommittee submitted substance supplemental application therapeutic tion toxicity Welfare
Popular passages
Page 642 - ... evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling or proposed labeling thereof.
Page 35 - ... a full list of the articles used as components of such drug; (3) a full statement of the composition of such drug; (4) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug...
Page 76 - Secretary pursuant to subsection (b), do not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling...
Page 44 - States shall be exempt from the requirements of section 505 (a) of the Act if the following conditions are complied with: (1) The label of such drug bears the statement "CAUTION: NEW DRUG LIMITED BY FEDERAL (OR UNITED STATES) LAW TO INVESTIGATIONAL USE...
Page 301 - Section l(a) and is a necessary incentive to call forth private risk capital and expense to bring the invention to the point of practical application.
Page 470 - Chairman, shall leave title to such invention in the employee, subject, however, to the reservation to the Government of a nonexclusive, irrevocable, royalty-free license in the invention with power to grant licenses for all governmental purposes...
Page 578 - Secretary finds (1) that clinical or other experience, tests, or other scientific data show that such drug is unsafe for use under the conditions of use upon the basis of which the application was approved...
Page 119 - ... drug, based on a fair evaluation of all material facts, is false or misleading in any particular and...
Page 121 - ... when the agency for good cause finds (and incorporates the finding and a brief statement of reasons therefor in the rules issued) that notice and public procedure thereon are impracticable, unnecessary, or contrary to the public interest.
Page 320 - ... he should retain the principal or exclusive rights for a further period of time, the government shall have the right to require the granting of a license to an applicant on a non-exclusive royalty free basis.